323 related articles for article (PubMed ID: 10548882)
21. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.
Sebti SM; Hamilton AD
Oncogene; 2000 Dec; 19(56):6584-93. PubMed ID: 11426643
[TBL] [Abstract][Full Text] [Related]
22. Selective modification of CaaX peptides with ortho-substituted anilinogeranyl lipids by protein farnesyl transferase: competitive substrates and potent inhibitors from a library of farnesyl diphosphate analogues.
Troutman JM; Subramanian T; Andres DA; Spielmann HP
Biochemistry; 2007 Oct; 46(40):11310-21. PubMed ID: 17854205
[TBL] [Abstract][Full Text] [Related]
23. [Protein farnesyl and geranylgeranyl transferases].
de Gunzburg J
C R Seances Soc Biol Fil; 1991; 185(5):290-305. PubMed ID: 1806188
[TBL] [Abstract][Full Text] [Related]
24. Regions outside of the CAAX motif influence the specificity of prenylation of G protein gamma subunits.
Kalman VK; Erdman RA; Maltese WA; Robishaw JD
J Biol Chem; 1995 Jun; 270(24):14835-41. PubMed ID: 7782351
[TBL] [Abstract][Full Text] [Related]
25. Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyltransferases farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cerevisiae.
Trueblood CE; Ohya Y; Rine J
Mol Cell Biol; 1993 Jul; 13(7):4260-75. PubMed ID: 8321228
[TBL] [Abstract][Full Text] [Related]
26. RhoGDI facilitates geranylgeranyltransferase-I-mediated RhoA prenylation.
Tnimov Z; Abankwa D; Alexandrov K
Biochem Biophys Res Commun; 2014 Oct; 452(4):967-73. PubMed ID: 25223799
[TBL] [Abstract][Full Text] [Related]
27. Substrate specificity determinants in the farnesyltransferase beta-subunit.
Trueblood CE; Boyartchuk VL; Rine J
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10774-9. PubMed ID: 9380709
[TBL] [Abstract][Full Text] [Related]
28. Role of the carboxyterminal residue in peptide binding to protein farnesyltransferase and protein geranylgeranyltransferase.
Roskoski R; Ritchie P
Arch Biochem Biophys; 1998 Aug; 356(2):167-76. PubMed ID: 9705207
[TBL] [Abstract][Full Text] [Related]
29. CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB.
Armstrong SA; Hannah VC; Goldstein JL; Brown MS
J Biol Chem; 1995 Apr; 270(14):7864-8. PubMed ID: 7713879
[TBL] [Abstract][Full Text] [Related]
30. Murine guanylate-binding protein: incomplete geranylgeranyl isoprenoid modification of an interferon-gamma-inducible guanosine triphosphate-binding protein.
Stickney JT; Buss JE
Mol Biol Cell; 2000 Jul; 11(7):2191-200. PubMed ID: 10888661
[TBL] [Abstract][Full Text] [Related]
31. [Isoprenylation of proteins: what is its role?].
Barbu VD
C R Seances Soc Biol Fil; 1991; 185(5):278-89. PubMed ID: 1806187
[TBL] [Abstract][Full Text] [Related]
32. Trafficking and signaling by fatty-acylated and prenylated proteins.
Resh MD
Nat Chem Biol; 2006 Nov; 2(11):584-90. PubMed ID: 17051234
[TBL] [Abstract][Full Text] [Related]
33. The development of protein farnesyltransferase inhibitors as signaling-based anticancer agents.
Ohkanda J; Blaskovich MA; Sebti SM; Hamilton AD
Prog Cell Cycle Res; 2003; 5():211-7. PubMed ID: 14593715
[TBL] [Abstract][Full Text] [Related]
34. Single prenyl-binding site on protein prenyl transferases.
Desnoyers L; Seabra MC
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12266-70. PubMed ID: 9770475
[TBL] [Abstract][Full Text] [Related]
35. Protein isoprenylation: the fat of the matter.
Crowell DN; Huizinga DH
Trends Plant Sci; 2009 Mar; 14(3):163-70. PubMed ID: 19201644
[TBL] [Abstract][Full Text] [Related]
36. Reversible inactivation of the transcriptional function of P53 protein by farnesylation.
Couderc B; Penary M; Tohfe M; Pradines A; Casteignau A; Berg D; Favre G
BMC Biotechnol; 2006 May; 6():26. PubMed ID: 16732889
[TBL] [Abstract][Full Text] [Related]
37. Novel isoprenoid modified proteins in Halobacteria.
Sagami H; Kikuchi A; Ogura K; Fushihara K; Nishino T
Biochem Biophys Res Commun; 1994 Sep; 203(2):972-8. PubMed ID: 8093082
[TBL] [Abstract][Full Text] [Related]
38. Peptide specificity of protein prenyltransferases is determined mainly by reactivity rather than binding affinity.
Hartman HL; Hicks KA; Fierke CA
Biochemistry; 2005 Nov; 44(46):15314-24. PubMed ID: 16285735
[TBL] [Abstract][Full Text] [Related]
39. Protein prenyltransferases.
Maurer-Stroh S; Washietl S; Eisenhaber F
Genome Biol; 2003; 4(4):212. PubMed ID: 12702202
[TBL] [Abstract][Full Text] [Related]
40. Protein prenylation: from discovery to prospects for cancer treatment.
Gelb MH; Scholten JD; Sebolt-Leopold JS
Curr Opin Chem Biol; 1998 Feb; 2(1):40-8. PubMed ID: 9667914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
